New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
05:37 EDTTHOR, HTWRThoratec downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Thoratec to Neutral citing the weaker LVAD market and limited visibility following the company's Q2 results. The firm lowered its price target for shares to $28 from $38. Goldman keeps a Sell rating on peer HeartWare (HTWR) and lowered its price target on the name to $73 from $75.
News For THOR;HTWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 30, 2015
07:16 EDTHTWRHeartWare reports Q1 adjusted EPS (55c), consensus (55c)
Subscribe for More Information
April 29, 2015
15:00 EDTHTWRNotable companies reporting before tomorrow's open
Subscribe for More Information
07:53 EDTHTWRHeartWare has a conference call hosted by JPMorgan
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use